Last reviewed · How we verify
Valeriana
At a glance
| Generic name | Valeriana |
|---|---|
| Also known as | Valeriana officinalis 50 mg |
| Sponsor | Marjan Industria e Comercio ltda |
| Drug class | Standardized Chemical Allergen [EPC] |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of the Efficacy of Dietary Supplementation in Targeting Sleep Quality (NutriSom-01B) (NA)
- The Effect of Valerian on Insomnia in Menopausal Women (NA)
- Feasibility Study on the Use of Redormin®500 on Day-time Cognition (PHASE4)
- Evaluation of a Combination of Plants in Anxiety-related Sleep Disorders: Randomized Trial Versus Placebo (NA)
- Clinical Trial on a Food Supplement With Melatonin and Herbal Products to Improve Sleep Quality (NA)
- Novel Formulation for Sleep Among People With Poor Sleep Quality (NA)
- Efficacy and Safety of Valerian Root Extract and Lavender Essential Oil Combination, Over 4 Weeks in Subjects With Sleep Complaints (PHASE2, PHASE3)
- Onnit Labs New Mood Supplementation in Healthy College Students (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Valeriana CI brief — competitive landscape report
- Valeriana updates RSS · CI watch RSS
- Marjan Industria e Comercio ltda portfolio CI